Commenting on her appointment, Ms
Contact:
VP
Investor Relations
T: +61 419 548 434
E: lisa.pendlebury@maynepharma.com
About
(C) 2022 Electronic News Publishing, source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.93 AUD | -2.39% | +4.05% | +12.68% |
02-26 | Mayne Pharma Group Swings to Loss in Fiscal H1 Despite Revenue Growth; Shares Jump 15% | MT |
02-25 | Transcript : Mayne Pharma Group Limited, H1 2024 Earnings Call, Feb 26, 2024 |
Commenting on her appointment, Ms
Contact:
VP
Investor Relations
T: +61 419 548 434
E: lisa.pendlebury@maynepharma.com
About
(C) 2022 Electronic News Publishing, source
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
177.6 EUR | +2.26% | +2.69% | 149B | ||
52.94 EUR | +1.22% | +4.21% | 63.06B | ||
1st Jan change | Capi. | |
---|---|---|
+12.68% | 367M | |
+19.62% | 43.34B | |
+20.44% | 21.96B | |
+10.86% | 14.09B | |
+13.07% | 13.64B | |
+37.46% | 11.43B | |
-8.59% | 6.86B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+8.46% | 5.22B |